Attenuated strain of pseudomonas as a vaccine for pseudomonas infection
US11045539B2 · kind B2 · utility
0Cited by
2References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 15, 2018 |
| Grant date | Jun 29, 2021 |
| Priority date | — |
| Expiry date | Feb 15, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/575
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure is related to a live-attenuated strain of Pseudomonas for its use as a vaccine, and for use in a method for preventive immunizing and for treating Pseudomonas infection, in particular in patients suffering from cystic fibrosis. Preferably, the live-attenuated strain of Pseudomonas is furthermore treated to become ‘killed but metabolically active’.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.